Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma. Duell J, Buck AK, Hartrampf PE, Schlotelburg W, et al. J Nucl Med 2023 Oct 5:jnumed.123.266074. doi: 10.2967/jnumed.123.266074.

Read + Share

Amedeo Smart

Independent Medical Education

Duell J, Buck AK, Hartrampf PE, Schlotelburg W, et al. Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma. J Nucl Med 2023 Oct 5:jnumed.123.266074. doi: 10.2967/jnumed.123.266074.
PMID: 37797975